All news articles for December 2020


Janssen acquires rights to novel AMD gene therapy

By Rachel Arthur

Janssen Pharmaceuticals, Inc. has acquired the rights to Hemera Biosciences’ investigational gene therapy HMR59: which has been designed to help preserve vision in patients with severe age-related macular degeneration (AMD).

Care home residents and workers are first in line for the COVID-19 vaccine. Pic:getty/interstid

UK rolls out COVID-19 vaccine: Who gets the first doses?

By Rachel Arthur

With the Pfizer/BioNTech COVID-19 vaccine authorized in the UK yesterday, the roll out of the first 800,000 doses will begin next week. 'We have spent months preparing for this day, so that as soon as we got the green light we would be ready to go,'...


Preparing for the pivot to downstream continuous processing

By Nick Taylor

Upstream processes were the focus of most early applications of continuous bioprocessing. That is now changing, with many biologic manufacturers evaluating downstream continuous processing and suppliers preparing their portfolios for the anticipated pivot...

© GettyImages/Shutter2U

Special Edition: The Future of Continuous BioProcessing

Addressing barriers to the shift to downstream continuous processing

By Nick Taylor

The shift away from batch downstream processing has moved closer in recent years amid progress on techniques such as antibody purification using continuous chromatography media. However, there remain barriers to clear before manufacturing facilities that...

Follow us


View more